 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval
, l# x: K5 ~/ Y0 Y/ `3 s. ?
8 Y. S( t, q7 O- h4 v9 y! rEDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
( L3 B+ e* y" ^: Q0 U2 W5 Y
4 h" d" r* O: r* m) E9 ^BY THE EDMONTON JOURNAL FEBRUARY 16, 20075 g- R4 `" N) O% { ]/ {. E
& U1 T( e: F3 Y' H# c7 `6 w/ }
: N/ N3 C5 M2 X7 \/ j- A6 AEDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
+ N% @$ M( E# C. A/ t9 S, J
* x# Q& d1 D' K2 w* L, u7 cThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."
7 x, j& n+ X9 V& i
1 b8 H7 x8 q- Q& S eThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
$ U, ?4 P2 C+ D
, v7 ~$ y0 O5 E# o) PIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.& x x( f" V' u$ k0 F# h
1 _7 x1 r( K) ~6 k: V9 v
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million. ]# `9 U4 e, @ o
6 A% I6 [0 i9 B. n5 v"As a scientist, it's one of the highlights of my CAREER," Shan said.
; a9 {! | ]( q8 e c2 [" Q# U+ s/ ^; J4 Z% I8 ?9 ^* I) n
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
* {( f4 i& Y; X# {7 Q! L4 a* @7 w$ I
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.! d9 r. u0 x( W* q
G A& V& {4 p/ B8 J7 q$ ^( |% B
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.. g& y3 n0 B2 r, t9 l
x/ N1 u X9 c WThe approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman.
: i0 O% h) r) X) s
- d* p* ]: T/ U# H# w" ]- D
O; L9 V) V nhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
- ^! [1 Z$ A2 Z, s
发表于 2015-2-28 19:45
